Photoprotective Effects of Selected Amino Acids on Naproxen Photodegradation in Aqueous Media.

HPLC UV/Vis spectroscopy analytical chemistry antioxidative activity chromatography photochemistry photodegradation photostability photostabilization

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
26 Jun 2020
Historique:
received: 28 05 2020
revised: 11 06 2020
accepted: 25 06 2020
entrez: 2 7 2020
pubmed: 2 7 2020
medline: 2 7 2020
Statut: epublish

Résumé

It is important to develop a photostabilization strategy to ensure the quality of photosensitive compounds, including pharmaceuticals. This study focused on the protective effects of 20 amino acids on the photodegradation of naproxen (NX), a photosensitive pharmaceutical, to clarify the important nature of a good photostabilizer. Our previous report indicated the photodegradability of NX and the protective effects of some antioxidants on its photodegradation, therefore, this compound was used as a model compound. The degradation of NX in aqueous media during ultraviolet light (UV) irradiation and the protective effects of selected amino acids were monitored through high-performance liquid chromatography (HPLC), equipped with a reverse-phase column. Addition of cysteine, tryptophan, and tyrosine induced the significant suppression of NX photodegradation after UV irradiation for 3 h (residual amount of NX; 15.35%, 6.82%, and 15.64%, respectively). Evaluation of the antioxidative activity and UV absorption spectrum showed that cysteine suppressed NX degradation through its antioxidative ability, while tryptophan and tyrosine suppressed it through their UV filtering ability. Furthermore, three amino acids at higher concentrations (more than 100 µmol/L) showed more protective effects on NX photodegradation. For 10 mmol/L, residual amounts of NX with cysteine, tryptophan, and tyrosine were 58.51%, 69.34%, and 82.40%, respectively. These results showed the importance of both photoprotective potencies (antioxidative potency and UV filtering potency) and stability to UV irradiation for a good photostabilizer of photosensitive pharmaceuticals.

Identifiants

pubmed: 32604908
pii: ph13060135
doi: 10.3390/ph13060135
pmc: PMC7345999
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP 20K15980

Références

Antioxidants (Basel). 2019 Sep 23;8(10):
pubmed: 31547495
Biomed Chromatogr. 2019 Jun;33(6):e4489
pubmed: 30652327
Photochem Photobiol. 2019 Jan;95(1):220-226
pubmed: 30403297
Photochem Photobiol. 1988 Feb;47(2):173-80
pubmed: 3344286
Environ Sci Pollut Res Int. 2014;21(13):7797-804
pubmed: 24638836
Chem Res Toxicol. 2009 Jan;22(1):173-78
pubmed: 18989938
J Photochem Photobiol B. 2014 Nov;140:36-40
pubmed: 25086322
Int J Pharm. 2019 Jun 10;564:492-498
pubmed: 31022505
Chemosphere. 2020 Feb;241:125111
pubmed: 31683437
Sci Total Environ. 2005 Sep 15;348(1-3):93-101
pubmed: 16162316
J Toxicol Sci. 2013;38(2):215-23
pubmed: 23535400
Toxicol Sci. 2010 Nov;118(1):236-50
pubmed: 20668001
Int J Pharm. 2018 Apr 25;541(1-2):19-25
pubmed: 29438725
Sci Total Environ. 2019 Nov 20;692:503-510
pubmed: 31351292
Int J Pharm. 2015 Oct 15;494(1):490-7
pubmed: 26307262
Chemosphere. 2020 Feb;240:124941
pubmed: 31726615
Chemosphere. 2019 Nov;235:867-875
pubmed: 31284135
Environ Sci Eur. 2018;30(1):47
pubmed: 30595997
AAPS PharmSciTech. 2018 Apr;19(3):1182-1190
pubmed: 29256152
J Pharm Pharmacol. 2002 Aug;54(8):1117-22
pubmed: 12195827
Biochem Biophys Res Commun. 1966 May 3;23(3):269-72
pubmed: 5960860
Photochem Photobiol. 2012 Jul-Aug;88(4):913-21
pubmed: 22443373

Auteurs

Kohei Kawabata (K)

Faculty of Pharmacy, Yasuda Women's University, 6-13-1 Yasuhigashi, Asaminami-ku, Hiroshima 731-0153, Japan.

Momoka Kanoh (M)

Faculty of Pharmacy, Yasuda Women's University, 6-13-1 Yasuhigashi, Asaminami-ku, Hiroshima 731-0153, Japan.

Mayu Okazaki (M)

Faculty of Pharmacy, Yasuda Women's University, 6-13-1 Yasuhigashi, Asaminami-ku, Hiroshima 731-0153, Japan.

Rina Maeda (R)

Faculty of Pharmacy, Yasuda Women's University, 6-13-1 Yasuhigashi, Asaminami-ku, Hiroshima 731-0153, Japan.

Satomi Mori (S)

Faculty of Pharmacy, Yasuda Women's University, 6-13-1 Yasuhigashi, Asaminami-ku, Hiroshima 731-0153, Japan.

Shiori Akimoto (S)

Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan.

Masanori Inagaki (M)

Faculty of Pharmacy, Yasuda Women's University, 6-13-1 Yasuhigashi, Asaminami-ku, Hiroshima 731-0153, Japan.

Hiroyuki Nishi (H)

Faculty of Pharmacy, Yasuda Women's University, 6-13-1 Yasuhigashi, Asaminami-ku, Hiroshima 731-0153, Japan.

Classifications MeSH